Top

Published in:

01-12-2016 | Focus Editorial

Focus on adequate antimicrobial treatment and de-escalation in the ICU

Authors: Dominique D. Benoit, Gordon Doig, Jean-Francois Timsit

Published in: Intensive Care Medicine | Issue 12/2016

Excerpt

Adequate antimicrobial treatment is considered of upmost importance to reduce mortality in critically ill patients with infection. However, because of the dramatic increase of antibiotic resistance worldwide [1, 2] and the delay in microbiological identification of pathogens, adequate antibiotic treatment is more easy to define retrospectively on chart review than to implement prospectively at the bedside. Several articles recently published in Intensive Care Medicine have provided some clues in how to improve adequate antimicrobial treatment in daily practice. …

Carlet J (2014) Ten tips on how to win the war against resistance to antibiotics. Intensive Care Med 41:899–901CrossRef

Bassetti M, Nicolau DP, Calandra T (2014) What’s new in antimicrobial use and resistance in critically ill patients. Intensive Care Med 40:422–426CrossRefPubMed

Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T, Wilcox M, Zahar JR, Poulakou G (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795CrossRefPubMed

Kollef MH (2014) What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med 40:92–95CrossRefPubMed

Paul M, Lador A, Grozinsky-Glasberg Leibovici L (2014) Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 7(1):CD003344

Paul M, Dickstein Y, Schlesinger A, Grozinsky-Glasberg S, Soares-Weiser L, Leibovici L (2013) Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database Syst Rev 29(6):CD003038

Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Phiippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP (2015) Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med 41:1181–1196CrossRefPubMed

de Lastours V, Chau F, Roy C, Larroque B, Fantin B (2014) Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone. J Antimicrob Chemother 69:3393–3400CrossRefPubMed

Haverkate MR, Derde LPG, Brun-Buisson C, Bonten MJM, Bootsma MCJ (2014) Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med 40:564–571CrossRefPubMedPubMedCentral

10.

De Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R (2014) Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med 40:998–1005CrossRefPubMed

11.

Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072–1083CrossRefPubMed

12.

De Waele JJ, Lipman J, Akova M, Bassetti M, Dimopoulos G, Kaukonen M, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Udy AA, Starr T, Wallis SC, Roberts JA (2014) Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically patients. Intensive Care Med 40:1340–1351CrossRefPubMed

13.

Matthaiou DK, De Waele J, Dimopoulos G (2014) What is new in the use of aminoglycosides in critically ill patients? Intensive Care Med 40:1553–1555CrossRefPubMed

14.

De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, Leroux-Roels I, Hoste E, Depuydt P, Decruyenaere J, Verstraete AG (2014) Therapeutic drug monitoring-based dose optimization of piperacillin and meropenem: a randomized controlled trial. Intensive Care Med 40:380–387CrossRefPubMed

15.

De Pascale G, Fortuna S, Tumbarello M, Cutuli SL, Vallecoccia MS, Spanu T, Bello G, Montini L, Pennisi MA, Navarra P, Antonelli M (2015) Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration. Intensive Care Med 41:103–110CrossRefPubMed

16.

Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernandez-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Marquez-Vacaro JA (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32–40CrossRefPubMed

17.

Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanèse J, Jaber S, Lepape A, Constantin JM, Papazian L, Bruder N, Allaouchiche B, Bézulier K, Antonini F, Textoris J, Martin C, for the AZUREA Network Investigators (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399–1408CrossRefPubMed

18.

Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49CrossRefPubMed

19.

Paul M, Dickstein Y, Raz-Pasteur A (2016) Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Inf: S1198-743X(16)30175-6. doi:10.1016/j.cmi.2016.05.023

20.

Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R (2015) Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:1071–1080CrossRefPubMedPubMedCentral

Title: Focus on adequate antimicrobial treatment and de-escalation in the ICU
Authors: Dominique D. Benoit
Gordon Doig
Jean-Francois Timsit
Publication date: 01-12-2016
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 12/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-016-4566-2

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Focus on adequate antimicrobial treatment and de-escalation in the ICU

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2016

Alternatives to antibiotics

Should we take into account ESBLs in empirical antibiotic treatment?

CAST: a new score for early prediction of neurological outcomes after cardiac arrest before therapeutic hypothermia with high accuracy

Understanding circulatory failure in sepsis

In 2035, will all bacteria be multiresistant? Yes

Refractory septic shock in children: a European Society of Paediatric and Neonatal Intensive Care definition